Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,928 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · derivative · entry 9 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,633 Underlying: Common Stock · 14,928 shares Expires 2025-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,479 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · derivative · entry 8 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 12,479 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 44,429 | $50.22 | $2,231,224.38 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · nonDerivative · entry 4 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,879 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 12,479 | $35.80 | $446,748.20 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 14,928 | $22.00 | $328,416.00 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 4,253 | $19.50 | $82,933.50 |
DisclosureSEC source: 0001562180-20-001112 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:21 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 300 | $50.00 | $15,000.00 |
DisclosureSEC source: 0001562180-20-001014 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,021 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:19 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-20-001013 · primarydocument.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,900 Underlying: Common Stock · 2,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares ("Initial Shares") and 116,831 of the shares subject to the option are contingent shares ("Contingent Shares"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:19 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 2,000 | $50.00 | $100,000.00 |
DisclosureSEC source: 0001562180-20-001013 · primarydocument.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:19 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 2,000 | $0.85 | $1,700.00 |
DisclosureSEC source: 0001562180-20-001013 · primarydocument.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,708 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · derivative · entry 9 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · derivative · entry 8 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,378 Underlying: Common Stock · 1,000 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 958 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · derivative · entry 7 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,561 Underlying: Common Stock · 958 shares Expires 2025-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 471 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · derivative · entry 6 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,979 Underlying: Common Stock · 471 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 5,637 | $50.00 | $281,850.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · nonDerivative · entry 5 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,648 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 471 | $35.80 | $16,861.80 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · nonDerivative · entry 4 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 958 | $22.00 | $21,076.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 1,000 | $19.50 | $19,500.00 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:23 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 2,708 | $13.09 | $35,447.72 |
DisclosureSEC source: 0001562180-20-001015 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:17 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,394 | $50.00 | $119,700.00 |
DisclosureSEC source: 0001562180-20-000453 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,321 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:16 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,200 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-20-000452 · primarydocument.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,900 Underlying: Common Stock · 3,200 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares ("Initial Shares") and 116,831 of the shares subject to the option are contingent shares ("Contingent Shares"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:16 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 3,200 | $50.01 | $160,032.00 |
DisclosureSEC source: 0001562180-20-000452 · primarydocument.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:16 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 3,200 | $0.85 | $2,720.00 |
DisclosureSEC source: 0001562180-20-000452 · primarydocument.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,622 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · derivative · entry 7 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,378 Underlying: Common Stock · 1,622 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,700 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · derivative · entry 6 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,519 Underlying: Common Stock · 2,700 shares Expires 2025-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · derivative · entry 5 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,450 Underlying: Common Stock · 800 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 5,922 | $50.00 | $296,100.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · nonDerivative · entry 4 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,148 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 800 | $35.80 | $28,640.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 2,700 | $22.00 | $59,400.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 21:18 UTC |
Simpson CurranSVP, Product Development & CTO
|
Exercise / conversionCommon Stock | 1,622 | $19.50 | $31,629.00 |
DisclosureSEC source: 0001562180-20-000454 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 16:18 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-20-000391 · primarydocument.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,100 Underlying: Common Stock · 30,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 354,100 shares, became exercisable as follows: 237,269 of the shares subject to the option are initial shares ("Initial Shares") and 116,831 of the shares subject to the option are contingent shares ("Contingent Shares"). 60,197 of the Initial Shares vested on September 17, 2014, 44,268 of the Initial Shares vested on September 17, 2015 and an additional 3,689 of the Initial Shares vested each month thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 16:18 UTC |
HAYDEN DONALD J JRDirector
|
SaleCommon Stock | 30,000 | $45.60 | $1,368,000.00 |
DisclosureSEC source: 0001562180-20-000391 · primarydocument.xml · nonDerivative · entry 2 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 16:18 UTC |
HAYDEN DONALD J JRDirector
|
Exercise / conversionCommon Stock | 30,000 | $0.85 | $25,500.00 |
DisclosureSEC source: 0001562180-20-000391 · primarydocument.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001562180-20-000321 · primarydocument.xml · derivative · entry 4 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,374 Underlying: Common Stock · 3,000 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 75,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 16:20 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 5,100 | $41.92 | $213,792.00 |
DisclosureSEC source: 0001562180-20-000321 · primarydocument.xml · nonDerivative · entry 3 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,715 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $41.70 to $42.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 16:20 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,400 | $41.40 | $99,360.00 |
DisclosureSEC source: 0001562180-20-000321 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,815 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.66 to $41.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $13.09 | $39,270.00 |
DisclosureSEC source: 0001562180-20-000321 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:22 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,600 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000217 · primarydocument.xml · derivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,600 Underlying: Common Stock · 42,600 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:23 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000218 · primarydocument.xml · derivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:20 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 270,000 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000214 · primarydocument.xml · derivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:21 UTC |
Vasista VittalChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000216 · primarydocument.xml · derivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Simpson CurranSVP, Product Development & CTO
|
GrantStock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000219 · primarydocument.xml · derivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 46,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:25 UTC |
Christmas Patrick J.SVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001562180-20-000220 · primarydocument.xml · derivative · entry 1 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer. Read SEC document |
| December 31, 2019 Filed Jan 6, 2021 08:53 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 302 | $34.82 | $10,517.00 |
DisclosureSEC source: 0001562180-21-000141 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,802 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of July 1, 2019 through December 31, 2019. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on December 31, 2019. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:24 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 6,153 | $44.26 | $272,331.78 |
DisclosureSEC source: 0001562180-19-006017 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,948 F1 · kind: This sale was made pursuant to the Reporting Person's election under the Issuer's equity incentive plan and applicable award agreement to satisfy tax withholding obligations through a "sell to cover" transaction in connection with the vesting of 39,500 restricted stock unit shares awarded on December 8, 2016. This sale does not represent a discretionary trade by the Reporting Person. F3 · price: This transaction was executed in multiple trades at prices ranging from $44.04 to $44.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:24 UTC |
Simpson CurranSVP, Product Development & CTO
|
SaleCommon Stock | 9,399 | $43.40 | $407,916.60 |
DisclosureSEC source: 0001562180-19-006017 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,101 F1 · kind: This sale was made pursuant to the Reporting Person's election under the Issuer's equity incentive plan and applicable award agreement to satisfy tax withholding obligations through a "sell to cover" transaction in connection with the vesting of 39,500 restricted stock unit shares awarded on December 8, 2016. This sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.038 to $44.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 20:12 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-19-004927 · primarydocument.xml · derivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,670 Underlying: Common Stock · 5,000 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 20:12 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 7,773 | $39.91 | $310,220.43 |
DisclosureSEC source: 0001562180-19-004927 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $39.43 to $40.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 20:12 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 2,227 | $39.19 | $87,276.13 |
DisclosureSEC source: 0001562180-19-004927 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,773 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.43 to $39.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 20:12 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 5,000 | $0.85 | $4,250.00 |
DisclosureSEC source: 0001562180-19-004927 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.